The increasing prevalence of obesity, rising incidence of type 2 diabetes, and growing demand for advanced metabolic disease treatments are driving the growth of the global Glucagon-Like Peptide-1 (GLP-1) Agonists Market. GLP-1 agonists are medications that mimic the action of the naturally occurring glucagon-like peptide-1 hormone, helping regulate blood glucose levels, support insulin...